The subsequent functional validation based on in vitro (LPS‐treated macrophage) and in vivo (NAFLD mouse) models demonstrated that three indole compounds were causally linked to the suppression of proinflammatory cytokines such as TNF‐α and IL‐1β. Here, IL1B is linked to metabolic dysfunction-associated steatotic liver disease.